Clinical Trials Browser

Phase EARLY_PHASE1 × Has results × Advanced B-cell Lymphoid Malignancies × Clear all

NCT01888952 2017-02-27

Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

Phase EARLY_PHASE1 Completed

10 enrolled 4 charts

Advanced B-cell Lymphoid Malignancies